Waters Corporation Q1 2026: Crushing Earnings & Growth Ahead

Waters Corporations Q1 2026 earnings soared after acquiring BDs Biosciences and Diagnostic Solutions, with total revenue reaching $1.267 billion, a 13% organic sales surge. New businesses contributed $520 million, exceeding expectations. Adjusted EPS climbed 20% to $2.70. Legacy Analytical Sciences grew 12%, while Biosciences and Diagnostic Solutions accelerated 7% and 8% respectively. Waters raised full-year organic growth to 6.5-8%, total revenue to $6.405-6.455 billion, and EPS to $14.40-14.60. Q2 guides organic at 6-8% constant currency, with total revenue $1.616-1.631 billion. Waters aims for mid-teens EPS gains through the decade. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9779075b761b3492